LY3298176 activated both GIP and GLP-1 receptor signaling in vitro and showed glucose-dependent insulin secretion and improved glucose tolerance by acting on both GIP and GLP-1 receptors in mice
$1,074 ($894 if paid in full) for 6 monthsone-time payment includes: Up to 180 mg of compounded liraglutide
It can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reflux
/ Be ready to discuss any history of stomach ulcers, kidney issues, or diabetes
Some patients feel tired for only a few days, while others notice fatigue for up to 2 months if they increase their dose too quickly
Finally, the duration of current pediatric clinical studies typically ranges from 1 to 2 years, which is insufficient to provide robust support for the long-term safety of GLP-1 RAs